1,2-Benzisothiazolin-3-oneCAS# 2634-33-5 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 2634-33-5 | SDF | Download SDF |
| PubChem ID | 17520 | Appearance | Powder |
| Formula | C7H5NOS | M.Wt | 151 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 1,2-benzothiazol-3-one | ||
| SMILES | C1=CC=C2C(=C1)C(=O)NS2 | ||
| Standard InChIKey | DMSMPAJRVJJAGA-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C7H5NOS/c9-7-5-3-1-2-4-6(5)10-8-7/h1-4H,(H,8,9) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
1,2-Benzisothiazolin-3-one Dilution Calculator
1,2-Benzisothiazolin-3-one Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 6.6225 mL | 33.1126 mL | 66.2252 mL | 132.4503 mL | 165.5629 mL |
| 5 mM | 1.3245 mL | 6.6225 mL | 13.245 mL | 26.4901 mL | 33.1126 mL |
| 10 mM | 0.6623 mL | 3.3113 mL | 6.6225 mL | 13.245 mL | 16.5563 mL |
| 50 mM | 0.1325 mL | 0.6623 mL | 1.3245 mL | 2.649 mL | 3.3113 mL |
| 100 mM | 0.0662 mL | 0.3311 mL | 0.6623 mL | 1.3245 mL | 1.6556 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Aesculuside B
Catalog No.:BCC8115
CAS No.:26339-92-4
- Escin IB
Catalog No.:BCN2970
CAS No.:26339-90-2
- 4-(cis)-Acetyl-3,6,8-trihydroxy-3-methyldihydronaphthalenone
Catalog No.:BCN1468
CAS No.:263368-92-9
- 4-(trans)-Acetyl-3,6,8-trihydroxy-3-methyldihydronaphthalenone
Catalog No.:BCN1469
CAS No.:263368-91-8
- (S)-(-)-Pindolol
Catalog No.:BCC6916
CAS No.:26328-11-0
- Perilloxin
Catalog No.:BCN6614
CAS No.:263249-77-0
- Dehydroperilloxin
Catalog No.:BCN7506
CAS No.:263241-09-4
- 22-Dehydroclerosterol
Catalog No.:BCN5141
CAS No.:26315-07-1
- Pepstatin A
Catalog No.:BCC1218
CAS No.:26305-03-3
- Physcion-8-O-beta-D-monoglucoside
Catalog No.:BCN8511
CAS No.:26296-54-8
- Ficaprenol 11
Catalog No.:BCN5140
CAS No.:26296-50-4
- 2,3',4,6-Tetrahydroxybenzophenone
Catalog No.:BCN5139
CAS No.:26271-33-0
- H-Arg-OMe.2HCl
Catalog No.:BCC2861
CAS No.:26340-89-6
- Rhodojaponin III
Catalog No.:BCN2809
CAS No.:26342-66-5
- H-Lys-OMe .2HCl
Catalog No.:BCC2981
CAS No.:26348-70-9
- Stachysterone D
Catalog No.:BCC8362
CAS No.:26361-67-1
- ESI-09
Catalog No.:BCC5504
CAS No.:263707-16-0
- PPT
Catalog No.:BCC7062
CAS No.:263717-53-9
- EMDT oxalate
Catalog No.:BCC7888
CAS No.:263744-72-5
- Buergerinin G
Catalog No.:BCN4659
CAS No.:263764-83-6
- 3,27-Dihydroxy-20(29)-lupen-28-oic acid methyl ester
Catalog No.:BCN1467
CAS No.:263844-79-7
- 3-Acetoxy-27-hydroxy-20(29)-lupen-28-oic acid methyl ester
Catalog No.:BCN1466
CAS No.:263844-80-0
- AG 045572
Catalog No.:BCC7464
CAS No.:263847-55-8
- S 25585
Catalog No.:BCC7687
CAS No.:263849-50-9
Suspect screening and non-targeted analysis of drinking water using point-of-use filters.[Pubmed:29182974]
Environ Pollut. 2018 Mar;234:297-306.
Monitored contaminants in drinking water represent a small portion of the total compounds present, many of which may be relevant to human health. To understand the totality of human exposure to compounds in drinking water, broader monitoring methods are imperative. In an effort to more fully characterize the drinking water exposome, point-of-use water filtration devices (Brita((R)) filters) were employed to collect time-integrated drinking water samples in a pilot study of nine North Carolina homes. A suspect screening analysis was performed by matching high resolution mass spectra of unknown features to molecular formulas from EPA's DSSTox database. Candidate compounds with those formulas were retrieved from the EPA's CompTox Chemistry Dashboard, a recently developed data hub for approximately 720,000 compounds. To prioritize compounds into those most relevant for human health, toxicity data from the US federal collaborative Tox21 program and the EPA ToxCast program, as well as exposure estimates from EPA's ExpoCast program, were used in conjunction with sample detection frequency and abundance to calculate a "ToxPi" score for each candidate compound. From approximately 15,000 molecular features in the raw data, 91 candidate compounds were ultimately grouped into the highest priority class for follow up study. Fifteen of these compounds were confirmed using analytical standards including the highest priority compound, 1,2-Benzisothiazolin-3-one, which appeared in 7 out of 9 samples. The majority of the other high priority compounds are not targets of routine monitoring, highlighting major gaps in our understanding of drinking water exposures. General product-use categories from EPA's CPCat database revealed that several of the high priority chemicals are used in industrial processes, indicating the drinking water in central North Carolina may be impacted by local industries.
